TL;DR
Get kitchen gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Multiple cultivated meat companies, including Believer Meats and Meatable, shut down in late 2025 due to funding shortages and high production costs. Despite $2.5 billion in prior investment, the sector faces a harsh reality check as venture capital timelines clash with long-term market viability.
The cultivated meat industry faced a severe contraction in late 2025, with several high-profile startups, including Believer Meats and Meatable, ceasing operations due to an inability to secure further funding. These closures mark a sharp reversal from the $2.5 billion in venture capital invested in the sector between 2021 and 2023, highlighting a growing disconnect between investor expectations and the long-term commercial reality of lab-grown protein.
Believer Meats, which had raised significant capital and built a $125 million manufacturing facility in North Carolina, shut down just weeks after receiving U.S. government approval. The company, valued at $600 million in 2021, failed to secure a last-ditch loan after losing a major financial backer, leaving its 200,000-square-foot factory empty and unused. Similarly, Dutch company Meatable ceased operations after acquiring Uncommon Bio’s platform, while UK-based CellRev and Netherlands-based Upstream Foods also announced closures due to missed commercial milestones and insufficient capital.
Investor Timelines Clash With Biomanufacturing Realities
The collapse of these companies underscores a fundamental mismatch between venture capital expectations and the biological timelines of cultivated meat production. Investors typically expect massive returns within five to seven years, but market viability for cultivated meat is not expected for at least another decade. The high cost of bioreactors, energy inputs, and specialized nutrient solutions has made scaling production prohibitively expensive, causing venture capital to turn cold on the sector despite earlier hype.
As an affiliate, we earn on qualifying purchases.
From Churchill’s Vision to Capital Flight
The concept of growing meat from cells dates back to a 1931 essay by Sir Winston Churchill, who predicted humanity would “escape the absurdity of growing a whole chicken.” By 2021, this vision seemed imminent, with entities like Tyson Foods and JBS investing alongside sovereign wealth funds. The technology involves harvesting stem cells from living animals and growing them in bioreactors. However, the initial frenzy of investment, tracked by the Good Food Institute, has given way to a sobering assessment of the industry’s economic feasibility.
“We shall escape the absurdity of growing a whole chicken in order to eat the breast or wing, by growing these parts separately under a suitable medium.”
— Sir Winston Churchill, 1931 essay ‘Fifty Years Hence’
As an affiliate, we earn on qualifying purchases.
Long-Term Viability Remains Unproven
It remains unclear whether the current wave of shutdowns represents a permanent collapse of the cultivated meat model or a necessary consolidation phase. While the environmental and animal welfare benefits are cited by proponents, the economic sustainability of producing meat without slaughter has not yet been proven at scale. Critics argue that the energy-intensive nature of biomanufacturing may make it less sustainable than traditional agriculture, a claim that remains a subject of ongoing scientific and economic debate.
As an affiliate, we earn on qualifying purchases.
Consolidation and Policy Shifts
The industry is likely to see further consolidation, with remaining players focusing on cost reduction and niche markets rather than mass-market replacement. Regulatory bodies, including the FDA, will continue to monitor safety standards, while investors may shift focus toward more immediate returns in alternative proteins or plant-based options. The sector’s future depends on breakthroughs in lowering production costs and achieving price parity with conventional meat.
As an affiliate, we earn on qualifying purchases.
Key Questions
Why did Believer Meats shut down?
Believer Meats shut down because it lost a major financial backer and could not secure a last-ditch loan, despite having a completed manufacturing plant and government approval.
How much was invested in cultivated meat recently?
According to the Good Food Institute, over $2.5 billion was invested in cultured meat and seafood companies between 2021 and 2023.
What is the main barrier to cultivated meat success?
The primary barriers are high production costs, including expensive bioreactors and nutrient solutions, and the long timeline required to achieve market viability, which conflicts with venture capital expectations.
Is cultivated meat safe to eat?
The FDA has approved certain cultivated meat products, indicating they meet safety standards. However, the broader industry faces challenges in proving economic viability rather than safety.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
